Google DeepMind released AlphaGenome 2, a conditional DNA sequence model that predicts regulatory activity and variant effects per cell type. It is available via the AlphaGenome API for non-commercial research.
The post Google DeepMind Releases AlphaGenome 2 for Cell-Type-Specific Variant Effects appeared first on MarkTechPost.